ARMK · Aramark - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q3 '24 | Q2 '24 | Q1 '24 | Q3 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $74.48M | $72.67M | - | $65.70M | $68.41M | $70.39M | $65.40M | $62.56M | $90.19M | $95.59M |
| Total Operating Expenses | $4.69B | $4.61B | - | $4.44B | $4.11B | $4.33B | $4.21B | $4.04B | $4.24B | $4.55B |
| D&A | $132.20M | $125.95M | - | - | - | $113.20M | - | - | $105.54M | - |
| Operating Income | $219.75M | $217.55M | - | $182.59M | $174.18M | $217.26M | $161.68M | $159.09M | $166.95M | $203.38M |
| Interest Expense | - | - | - | - | - | - | $112.23M | $86.38M | $114.56M | - |
| Income Tax | $35.37M | $39.13M | - | $24.23M | $22.50M | $35.76M | $22.08M | $19.71M | $23.87M | $128.05M |
| Net Income | $101.95M | $96.16M | - | $71.78M | $61.85M | $105.62M | $58.13M | $53.45M | $28.54M | $338.48M |
| EPS - Basic | $0.39 | $0.37 | - | $0.27 | $0.23 | $0.40 | $0.22 | $0.20 | $0.11 | $0.94 |
| EPS - Diluted | $0.38 | $0.36 | - | $0.27 | $0.23 | $0.39 | $0.22 | $0.20 | $0.11 | $0.93 |
Balance Sheet
| Line item | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q3 '24 | Q2 '24 | Q1 '24 | Q3 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $475.72M | $439.63M | $639.10M | $501.49M | $920.46M | $484.15M | $672.48M | $356.61M | $295.60M | $1.96B |
| Accounts Receivable | $2.48B | $2.50B | $2.21B | $2.36B | $2.23B | $2.20B | $2.10B | $2.22B | $2.20B | $2.36B |
| Inventory | $453.32M | $414.61M | $418.77M | $394.21M | $405.86M | $366.69M | $387.60M | $388.28M | $367.61M | $578.43M |
| Accounts Payable | $1.25B | $1.28B | $1.52B | $1.14B | $1.14B | $1.10B | $1.39B | $1.10B | $1.10B | $1.41B |
| Current Assets | $3.75B | $3.63B | $3.52B | $3.53B | $3.84B | $3.29B | $3.41B | $3.33B | $3.17B | $5.22B |
| Total Assets | $13.84B | $13.54B | $13.30B | $13.28B | $13.49B | $12.71B | $12.67B | $12.56B | $12.42B | $16.87B |
| Current Liabilities | $3.09B | $2.86B | $3.55B | $2.74B | $3.18B | $3.50B | $4.21B | $2.66B | $2.49B | $5.03B |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - | - | - | - | - | - |
| Stockholders' Equity | $3.28B | $3.21B | $3.15B | $3.08B | $3.02B | $3.08B | $3.04B | $2.89B | $2.85B | $3.71B |
| Retained Earnings | $586.26M | $515.84M | $453.28M | $393.74M | $349.50M | $315.47M | $239.71M | $110.88M | $79.30M | $964.16M |
Cash Flow
| Line item | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q3 '24 | Q2 '24 | Q1 '24 | Q3 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | ($782.20M) | - | - | - | ($657.08M) | - | - | ($615.75M) | - |
| Investing Cash Flow | - | ($153.72M) | - | - | - | ($197.97M) | - | - | ($71.19M) | - |
| Financing Cash Flow | - | $735.70M | - | - | - | ($779.00M) | - | - | $662.53M | - |
| CapEx | - | $122.16M | - | - | - | $119.86M | - | - | $115.62M | - |
| Free Cash Flow | - | ($904.36M) | - | - | - | ($776.94M) | - | - | ($731.37M) | - |
Ratios
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q3 '24 | Q2 '24 | Q1 '24 | Q3 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | - | - | - | - |
| Operating margin | - | - | - | - | - | - | - | - | - | - |
| EBITDA margin | - | - | - | - | - | - | - | - | - | - |
| Net margin | - | - | - | - | - | - | - | - | - | - |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | - |
| FCF / Net income | - | -9.40 | - | - | - | -7.36 | - | - | -25.63 | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | - | - | - | - | - | - | - | - | - | - |
| Effective tax rate | 25.8% | 28.9% | - | 25.2% | 26.7% | 25.3% | 27.5% | 26.9% | 45.5% | 27.4% |
| Return on assets | 0.7% | 0.7% | - | 0.5% | 0.5% | 0.8% | 0.5% | 0.4% | 0.2% | 2.0% |
| Return on equity | 3.1% | 3.0% | - | 2.3% | 2.0% | 3.4% | 1.9% | 1.8% | 1.0% | 9.1% |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 1.21 | 1.27 | 0.99 | 1.29 | 1.21 | 0.94 | 0.81 | 1.25 | 1.27 | 1.04 |
| Quick ratio | 1.07 | 1.13 | 0.88 | 1.14 | 1.08 | 0.84 | 0.72 | 1.11 | 1.12 | 0.92 |
| Cash ratio | 0.15 | 0.15 | 0.18 | 0.18 | 0.29 | 0.14 | 0.16 | 0.13 | 0.12 | 0.39 |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | - | - | - | - | - | - | 1.4x | 1.8x | 1.5x | - |
| Equity multiplier | 4.22 | 4.22 | 4.23 | 4.31 | 4.47 | 4.12 | 4.17 | 4.34 | 4.36 | 4.54 |
| Liabilities / Assets | - | - | - | - | - | - | - | - | - | - |
| Efficiency | ||||||||||
| Asset turnover | - | - | - | - | - | - | - | - | - | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | 112.0x | 101.6x | - | 155.9x | 148.7x | 96.0x | 174.7x | 162.6x | 255.5x | 26.9x |
| P / B | 3.5x | 3.0x | - | 3.6x | 3.0x | 3.3x | 3.4x | 3.0x | 2.6x | 1.8x |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | 30.9x | 27.1x | - | - | - | 29.0x | - | - | 26.2x | - |
| Growth | ||||||||||
| Revenue growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | 26.2% | 0.1% | - | 12.9% | 9.5% | 30.1% | -20.5% | -12.6% | -16.4% | 37.5% |
| Net income growth (YoY) | 64.8% | -9.0% | - | 23.5% | 15.7% | 270.1% | -82.8% | -4.6% | -61.5% | 739.3% |
| EPS growth (YoY) | 65.2% | -7.7% | - | 22.7% | 15.0% | 254.5% | -76.4% | -4.8% | -60.7% | 482.1% |
| EPS CAGR (3y) | 21.9% | 8.7% | - | 19.1% | 18.0% | 31.9% | 19.2% | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | -7.3% | -7.8% | 10.8% | -35.6% | 26.3% |
| FCF growth (YoY) | - | -16.4% | - | - | - | -6.2% | - | - | -3.0% | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | 8.6% | 4.1% | - | 1.5% | 4.5% | 8.3% | -18.1% | -9.2% | -9.4% | 27.4% |
Peer comparison
Same SIC group: Retail-Eating Places
Comparing Aramark against the 5 most active filers in the same SIC group.
Dividends
$0.46/share trailing 12 months · +13.4% YoY
| Ex-date | Per share |
|---|---|
| May 20, 2026 | $0.1200 |
| Feb 18, 2026 | $0.1200 |
| Dec 5, 2025 | $0.1200 |
| Aug 6, 2025 | $0.1050 |
| May 14, 2025 | $0.1050 |
| Feb 10, 2025 | $0.1050 |
| Dec 2, 2024 | $0.1050 |
| Aug 19, 2024 | $0.0950 |
| May 10, 2024 | $0.0950 |
| Feb 13, 2024 | $0.0950 |
| Nov 27, 2023 | $0.0950 |
| Aug 15, 2023 | $0.0794 |
| May 16, 2023 | $0.0794 |
| Feb 21, 2023 | $0.0794 |
| Nov 21, 2022 | $0.0794 |
| Aug 16, 2022 | $0.0794 |
| May 17, 2022 | $0.0794 |
| Feb 15, 2022 | $0.0794 |
| Nov 29, 2021 | $0.0794 |
| Aug 24, 2021 | $0.0794 |
| May 25, 2021 | $0.0794 |
| Feb 16, 2021 | $0.0794 |
| Nov 30, 2020 | $0.0794 |
| Aug 18, 2020 | $0.0794 |